We Built a $335 Million Power Plant in Afghanistan that Can Barely Turn on Lightbulb
USAID is denying that a $335 million “vital component” of their mission to aid the massive energy deficit in Kabul, Afghanistan is an utter failure, but a new report contradicts that claim.
A power plant built by U.S. Agency for International Development (USAID) is extremely underused and in danger of being wasted, according to the Special Inspector General for Afghanistan Reconstruction (SIGAR). USAID attempted to defend itself by saying the plant was only built to provide occasional backup and insurance for Kabul’s electrical grid, not for electrical power on a continuous basis. SIGAR’s report provides evidence that the plant was built for regular usage.
Related: U.S. Military Builds a $15 Million Warehouse That Nobody Wants
First, the basis of design was for a base load plant, built to operate 24 hours per day, 7 days a week. Also, the plant hasn’t made any impact on reducing Kabul’s massive energy deficit that USAID says is one of the plant’s main priorities. Not only is it not being used regularly, but it’s not even contributing additional electricity to increase the overall power supply in Kabul.
The Tarakhil Power Plant was built in July 2007 on the outskirts of Kabul, with the intention of supplying 18 diesel engines worth of operating power. Since Da Afghanistan Breshna Sherkat (DABS) – Afghanistan’s national power utility – assumed responsibility for the operation and maintenance of the facility in 2010, the plant has only performed at a shred of its total capability. Between July 2010 and December 2013, the USAID IG found that the plant performed at a mere 2.2 percent of its potential.
Since the Tarakhil Power Plant was used incorrectly and only on an intermittent basis, the plant has suffered premature wear and tear on its engine and electrical components. The damage is expected to raise already steep operation and maintenance costs.
Top Reads from the Fiscal Times:
- How ‘King Coal’ Could Swing the 2016 Election
- Kerry to Congress: Sign the Iran Deal or the Dollar Gets Hit
- China’s Currency Devaluation Brings Stocks to a 'Death Cross'
Chart of the Day: SALT in the GOP’s Wounds
The stark and growing divide between urban/suburban and rural districts was one big story in this year’s election results, with Democrats gaining seats in the House as a result of their success in suburban areas. The GOP tax law may have helped drive that trend, Yahoo Finance’s Brian Cheung notes.
The new tax law capped the amount of state and local tax deductions Americans can claim in their federal filings at $10,000. Congressional seats for nine of the top 25 districts where residents claim those SALT deductions were held by Republicans heading into Election Day. Six of the nine flipped to the Democrats in last week’s midterms.
Chart of the Day: Big Pharma's Big Profits
Ten companies, including nine pharmaceutical giants, accounted for half of the health care industry's $50 billion in worldwide profits in the third quarter of 2018, according to an analysis by Axios’s Bob Herman. Drug companies generated 23 percent of the industry’s $636 billion in revenue — and 63 percent of the total profits. “Americans spend a lot more money on hospital and physician care than prescription drugs, but pharmaceutical companies pocket a lot more than other parts of the industry,” Herman writes.
Chart of the Day: Infrastructure Spending Over 60 Years
Federal, state and local governments spent about $441 billion on infrastructure in 2017, with the money going toward highways, mass transit and rail, aviation, water transportation, water resources and water utilities. Measured as a percentage of GDP, total spending is a bit lower than it was 50 years ago. For more details, see this new report from the Congressional Budget Office.
Number of the Day: $3.3 Billion
The GOP tax cuts have provided a significant earnings boost for the big U.S. banks so far this year. Changes in the tax code “saved the nation’s six biggest banks $3.3 billion in the third quarter alone,” according to a Bloomberg report Thursday. The data is drawn from earnings reports from Bank of America, Citigroup, Goldman Sachs, JPMorgan Chase, Morgan Stanley and Wells Fargo.
Clarifying the Drop in Obamacare Premiums
We told you Thursday about the Trump administration’s announcement that average premiums for benchmark Obamacare plans will fall 1.5 percent next year, but analyst Charles Gaba says the story is a bit more complicated. According to Gaba’s calculations, average premiums for all individual health plans will rise next year by 3.1 percent.
The difference between the two figures is produced by two very different datasets. The Trump administration included only the second-lowest-cost Silver plans in 39 states in its analysis, while Gaba examined all individual plans sold in all 50 states.